Premium
Molecular cloning and expression of a variant form of hippostasin/ KLK11 in prostate
Author(s) -
Nakamura Terukazu,
Mitsui Shinichi,
Okui Akira,
Miki Tsuneharu,
Yamaguchi Nozomi
Publication year - 2003
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.10191
Subject(s) - prostate , cloning (programming) , prostate disease , prostate cancer , medicine , molecular cloning , expression (computer science) , biology , computational biology , gene expression , genetics , gene , cancer , computer science , programming language
Background Hippostasin is a kallikrein‐like serine protease, which has two alternatively spliced isoforms, brain‐type and prostate‐type. We previously reported alternative expression of hippostasin in prostate cancer cell lines. Methods We studied the expression of a variant‐form hippostasin (isoform 3) mRNA by RT‐PCR. Localization of the isoform 3 protein was examined by immunohistochemistry. The enzymatic activity of the recombinant protein was measured with synthetic substrates. Results A novel isoform of hippostasin contains 25 additional amino acids in the catalytic triad of brain‐type hippostasin. Its mRNA was expressed in normal prostate tissue, BPH, and prostate cancer cell lines. The protein was localized in the prostate secretory epithelium. The enzyme activity was similar to that of brain‐type hippostasin, which has kallikrein‐like activity. Conclusions In this study, we have identified a third isoform of hippostasin, which was designated variant‐form (isoform 3). Hippostasin isoform 3 may play a role in the prostate, including reproductive and/or tumorigenic functions. Prostate 54: 299–305, 2003. © 2003 Wiley‐Liss, Inc.